Search results

Order by most recent / most popular / relevance

Results: 1-10 of 471

Supreme Court invalidates claims to isolated DNA, but upholds patent eligibility of cDNA in Myriad

Edwards Wildman Palmer LLP
-
USA
-
June 13 2013

On June 13, 2013, the United States Supreme Court issued a highly anticipated decision in Association for Molecular Pathology v. Myriad Genetics, Inc

Time to review your ADA policy: DSM-5 revisions could mean new requests for accommodation

Edwards Wildman Palmer LLP
-
USA
-
June 5 2013

The American Psychiatric Association has published the latest revision to the Diagnostic Statistical Manual (the "DSM-5"), which could expose

CMS releases shop program rule; White House memorandum updates exchange progress

Edwards Wildman Palmer LLP
-
USA
-
June 5 2013

On May 31, the Centers for Medicare & Medicaid Services (CMS) released a final rule on the Small Business Health Options Program, part of the

New guidance issued on “fixed indemnity” insurance benefits under Affordable Care Act

Edwards Wildman Palmer LLP
-
USA
-
April 18 2013

When the Health Insurance Portability and Accountability Act (“HIPAA”) was enacted in 1996, it exempted coverage of “excepted benefits” from its

Attention pharmaceutical and medical device executives ignorance is not bliss

Edwards Wildman Palmer LLP
-
USA
-
October 31 2012

The recent sentencings of a number of executives on so-called "Park pleas" serve as an important reminder that the United States Department of Justice, working with the Food and Drug Administration, holds managers, officers, and in-house counsel at drug and medical device companies to a high standard with respect to overseeing the safe manufacture and delivery of drugs and medical devices to consumers

CCIIO issues broker guidelines for exchanges

Edwards Wildman Palmer LLP
-
USA
-
May 7 2013

On May 1, the Center for Consumer Information and Insurance Oversight (CCIIO), a part of the Centers for Medicare and Medicaid Services (CMS), issued

Plastic additive Bisphenola: product liability class actions on the rise

Edwards Wildman Palmer LLP
-
USA
-
May 15 2008

Over the past two months, four separate class actions have been filed against the manufacturers and distributors of plastic products containing BisphenolA (BPA

Patentability of methods of medical treatment and medical devices in Europe

Edwards Wildman Palmer LLP
-
European Union
-
May 7 2009

The European Patent Convention (EPC) proscribes the patenting of methods of medical treatment

HIPAA enforcement rule sets standards for penalties: will your HIPAA compliance program stand up?

Edwards Wildman Palmer LLP
-
USA
-
March 12 2013

As we reported here and here, the U.S. Department of Health and Human Services ("HHS") recently issued final regulations (the "Omnibus Final Rule"

Don't breach a warranty through failure to fulfil a third party contract

Edwards Wildman Palmer LLP
-
United Kingdom
-
May 13 2013

When entering into a contract, one party may be asked to give warranties to the other party relating to a number of different aspects of the state of

next >

Search results

Supreme Court invalidates claims to isolated DNA, but upholds patent eligibility of cDNA in Myriad

Time to review your ADA policy: DSM-5 revisions could mean new requests for accommodation

CMS releases shop program rule; White House memorandum updates exchange progress

New guidance issued on “fixed indemnity” insurance benefits under Affordable Care Act

Attention pharmaceutical and medical device executives ignorance is not bliss

CCIIO issues broker guidelines for exchanges

Plastic additive Bisphenola: product liability class actions on the rise

Patentability of methods of medical treatment and medical devices in Europe

HIPAA enforcement rule sets standards for penalties: will your HIPAA compliance program stand up?

Don't breach a warranty through failure to fulfil a third party contract

Current Search

Suggested Facets

Author

Jurisdiction

Workarea